Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BI's cancer drug afatinib gets US fast-track review
BI's cancer drug afatinib gets US fast-track review
BI's cancer drug afatinib gets US fast-track review
Submitted by
admin
on January 16, 2013 - 8:38am
Source:
Pharma Times, UK
News Tags:
Afatinib
Boehringer Ingelheim
fast track
non-small cell lung cancer
Headline:
BI's cancer drug afatinib gets US fast-track review
Do Not Allow Advertisers to Use My Personal information
